Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

388 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease).
Abrera-Abeleda MA, Nishimura C, Smith JL, Sethi S, McRae JL, Murphy BF, Silvestri G, Skerka C, Józsi M, Zipfel PF, Hageman GS, Smith RJ. Abrera-Abeleda MA, et al. J Med Genet. 2006 Jul;43(7):582-9. doi: 10.1136/jmg.2005.038315. Epub 2005 Nov 18. J Med Genet. 2006. PMID: 16299065 Free PMC article.
Soluble CR1 therapy improves complement regulation in C3 glomerulopathy.
Zhang Y, Nester CM, Holanda DG, Marsh HC, Hammond RA, Thomas LJ, Meyer NC, Hunsicker LG, Sethi S, Smith RJ. Zhang Y, et al. J Am Soc Nephrol. 2013 Nov;24(11):1820-9. doi: 10.1681/ASN.2013010045. Epub 2013 Aug 1. J Am Soc Nephrol. 2013. PMID: 23907509 Free PMC article.
Defining the complement biomarker profile of C3 glomerulopathy.
Zhang Y, Nester CM, Martin B, Skjoedt MO, Meyer NC, Shao D, Borsa N, Palarasah Y, Smith RJ. Zhang Y, et al. Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1876-82. doi: 10.2215/CJN.01820214. Epub 2014 Oct 23. Clin J Am Soc Nephrol. 2014. PMID: 25341722 Free PMC article.
High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies.
Bu F, Borsa NG, Jones MB, Takanami E, Nishimura C, Hauer JJ, Azaiez H, Black-Ziegelbein EA, Meyer NC, Kolbe DL, Li Y, Frees K, Schnieders MJ, Thomas C, Nester C, Smith RJ. Bu F, et al. J Am Soc Nephrol. 2016 Apr;27(4):1245-53. doi: 10.1681/ASN.2015040385. Epub 2015 Aug 17. J Am Soc Nephrol. 2016. PMID: 26283675 Free PMC article.
Complement inhibition in C3 glomerulopathy.
Nester CM, Smith RJ. Nester CM, et al. Semin Immunol. 2016 Jun;28(3):241-9. doi: 10.1016/j.smim.2016.06.002. Epub 2016 Jul 9. Semin Immunol. 2016. PMID: 27402056 Review.
Characterization of C3 in C3 glomerulopathy.
Sethi S, Vrana JA, Fervenza FC, Theis JD, Sethi A, Kurtin PJ, Zhang Y, Smith RJH. Sethi S, et al. Among authors: smith rjh. Nephrol Dial Transplant. 2017 Mar 1;32(3):459-465. doi: 10.1093/ndt/gfw290. Nephrol Dial Transplant. 2017. PMID: 27507892
C4 Nephritic Factors in C3 Glomerulopathy: A Case Series.
Zhang Y, Meyer NC, Fervenza FC, Lau W, Keenan A, Cara-Fuentes G, Shao D, Akber A, Fremeaux-Bacchi V, Sethi S, Nester CM, Smith RJH. Zhang Y, et al. Among authors: smith rjh. Am J Kidney Dis. 2017 Dec;70(6):834-843. doi: 10.1053/j.ajkd.2017.07.004. Epub 2017 Aug 24. Am J Kidney Dis. 2017. PMID: 28838767 Free PMC article.
388 results